2022 Q3 Form 10-Q Financial Statement

#000190798222000006 Filed on August 26, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2021 Q4
Revenue $1.695M $1.371M $0.00
YoY Change 20.58%
Cost Of Revenue $609.0K $586.0K $1.750M
YoY Change 98.37% 30.8%
Gross Profit $1.086M $785.0K $4.529M
YoY Change 8.6% 13.93%
Gross Profit Margin 64.07% 57.26%
Selling, General & Admin $9.020M $5.698M $18.08M
YoY Change 101.34% 52.6%
% of Gross Profit 830.57% 725.86% 399.12%
Research & Development $7.334M $7.072M $25.40M
YoY Change 16.17% 12.41%
% of Gross Profit 675.32% 900.89% 560.85%
Depreciation & Amortization $338.0K $309.0K $1.534M
YoY Change -13.99% -10.17%
% of Gross Profit 31.12% 39.36% 33.87%
Operating Expenses $16.35M $12.77M $810.7K
YoY Change 997.75% 27.38%
Operating Profit -$15.27M -$11.99M $3.718M
YoY Change 55.91% 28.37%
Interest Expense $1.336M $1.746M -$27.51M
YoY Change -88.95% 743.48%
% of Operating Profit -739.92%
Other Income/Expense, Net $2.215M -$1.213M $27.92M
YoY Change -57187.63% -125.99%
Pretax Income -$13.05M -$13.20M -$400.8K
YoY Change -223.23% 889.38%
Income Tax $10.42K
% Of Pretax Income
Net Earnings -$13.10M -$13.20M -$411.2K
YoY Change -223.67% 182.73%
Net Earnings / Revenue -772.86% -962.65%
Basic Earnings Per Share -$0.11 -$0.12
Diluted Earnings Per Share -$0.11 -$0.12 -$10.96K
COMMON SHARES
Basic Shares Outstanding 61.60M shares 112.0M shares
Diluted Shares Outstanding 116.3M shares 112.0M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.76M $10.47M $124.7K
YoY Change 5437.05% 2861.27%
Cash & Equivalents $13.76M $10.50M $9.500M
Short-Term Investments
Other Short-Term Assets $8.190M $7.200M $176.2K
YoY Change 3078.48% 2014.91%
Inventory $2.533M $2.148M $2.114M
Prepaid Expenses
Receivables $740.0K $918.0K $421.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $26.28M $23.18M $19.16M
YoY Change 5090.91% 3241.07%
LONG-TERM ASSETS
Property, Plant & Equipment $2.537M $2.772M $3.249M
YoY Change
Goodwill
YoY Change
Intangibles $262.0K $262.0K $272.0K
YoY Change
Long-Term Investments $300.2M
YoY Change
Other Assets $1.345M $1.350M $1.353M
YoY Change
Total Long-Term Assets $12.21M $12.50M $13.45M
YoY Change -95.93% -95.83%
TOTAL ASSETS
Total Short-Term Assets $26.28M $23.18M $19.16M
Total Long-Term Assets $12.21M $12.50M $13.45M
Total Assets $38.49M $35.69M $32.61M
YoY Change -87.2% -88.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.158M $2.483M $2.889M
YoY Change 38.92% 155.67%
Accrued Expenses $5.318M $8.295M $3.614M
YoY Change
Deferred Revenue $1.989M $2.595M $2.665M
YoY Change
Short-Term Debt $420.0K $0.00 $0.00
YoY Change
Long-Term Debt Due $2.232M $21.35M $220.0K
YoY Change
Total Short-Term Liabilities $14.58M $36.30M $10.30M
YoY Change 541.27% 3637.7%
LONG-TERM LIABILITIES
Long-Term Debt $12.91M $12.90M $12.23M
YoY Change
Other Long-Term Liabilities $0.00 $0.00 $18.00K
YoY Change -100.0% -100.0%
Total Long-Term Liabilities $12.91M $12.90M $12.25M
YoY Change -40.39% -61.73%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.58M $36.30M $10.30M
Total Long-Term Liabilities $12.91M $12.90M $12.25M
Total Liabilities $39.20M $55.78M $29.59M
YoY Change 63.78% 60.78%
SHAREHOLDERS EQUITY
Retained Earnings -$363.1M -$350.1M -$325.3M
YoY Change
Common Stock $11.00K $2.811M $2.610M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$710.0K -$20.09M $3.020M
YoY Change
Total Liabilities & Shareholders Equity $38.49M $35.69M $32.61M
YoY Change -87.2% -88.14%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2021 Q4
OPERATING ACTIVITIES
Net Income -$13.10M -$13.20M -$411.2K
YoY Change -223.67% 182.73%
Depreciation, Depletion And Amortization $338.0K $309.0K $1.534M
YoY Change -13.99% -10.17%
Cash From Operating Activities -$12.77M -$11.99M -$139.6K
YoY Change 14233.33% 1539.95%
INVESTING ACTIVITIES
Capital Expenditures -$98.00K -$74.00K -$1.999M
YoY Change -85.93%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$98.00K -$74.00K $0.00
YoY Change -85.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 16.13M 4.893M 15.75K
YoY Change -102531.75% 308.09%
NET CHANGE
Cash From Operating Activities -12.77M -11.99M -139.6K
Cash From Investing Activities -98.00K -74.00K 0.000
Cash From Financing Activities 16.13M 4.893M 15.75K
Net Change In Cash 3.264M -7.171M -123.9K
YoY Change -3213.02% 880.82%
FREE CASH FLOW
Cash From Operating Activities -$12.77M -$11.99M -$139.6K
Capital Expenditures -$98.00K -$74.00K -$1.999M
Free Cash Flow -$12.67M -$11.92M $1.859M
YoY Change 5709.28%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001907982
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41468
dei Entity Registrant Name
EntityRegistrantName
D-WAVE QUANTUM INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
88-1068854
dei Entity Address Address Line1
EntityAddressAddressLine1
3033 Beta Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
Burnaby
dei Entity Address State Or Province
EntityAddressStateOrProvince
BC
dei Entity Address Country
EntityAddressCountry
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
V5G 4M9
dei City Area Code
CityAreaCode
604
dei Local Phone Number
LocalPhoneNumber
630-1428
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
61598331 shares
us-gaap Nature Of Operations
NatureOfOperations
Background and Nature of Operations<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D-Wave Quantum Inc. ("D-Wave" or the “Company”) was incorporated as a corporation organized and existing under the General Corporation Law of the State of the Delaware on January 24, 2022. The Company was formed for the purpose of effecting a merger between DPCM Capital, Inc. (“DPCM”), D-Wave Systems Inc. (“D-Wave Systems”), and certain other affiliated entities through a series of transactions (the “Business Combination”) pursuant to the definitive agreement entered into on February 7, 2022 (the “Transaction Agreement”). On August 5, 2022, in conjunction with the Business Combination, DPCM and D-Wave Systems became wholly owned subsidiaries of and are operated by the Company. Upon the completion of the Business Combination, the Company succeeded to substantially all of the operations of its predecessor, D-Wave Systems. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the Business Combination, D-Wave Systems and the Company entered into an agreement with Lincoln Park Capital Fund LLC (the "Investor") on June 16, 2022 which provides D-Wave the sole right, but not the obligation, to direct the Investor to buy specified dollar amounts up to $150.0 million of D-Wave's par value $0.0001 per share common stock through an Equity Line of Credit ("ELOC"). The ELOC will provide D-Wave Systems and the Company with additional liquidity to fund the business, subject to the conditions set forth in the agreement. </span></div>Description of business<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D-Wave Systems is a commercial quantum computing company that provides customers with a full suite of professional services and web-based access to its superconducting quantum computer systems and integrated software environment through its cloud service, Leap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. References to the “Company” in these D-Wave Systems Inc. Notes to Condensed Consolidated Financial Statements (Unaudited) for the periods before April 14, 2020, shall be to D-Wave Inc., a federally incorporated corporation and its subsidiaries, collectively. References to the “Company” from April 14, 2020 to December 31, 2020 (inclusive) shall be to DWSI Holdings Inc. and its subsidiaries, collectively. References to the “Company” herein for the periods including and after January 1, 2021, shall be to D-Wave Systems and its subsidiaries, collectively. Historically, the Company has developed its own annealing superconducting quantum computer systems and associated software and its current-generation quantum system is the D-Wave Advantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. During the year ended December 31, 2021, the Company initiated the development of a gate-model quantum computing system. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D-Wave Systems is a British Columbia corporation headquartered in Burnaby, British Columbia, and is an indirect subsidiary of D-Wave as a result of the Business Combination, as described in more detail in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 12 - Subsequent events</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six month periods ended June 30, 2022 and 2021, the Company’s revenue was derived primarily from customers located in the United States, Japan, and Germany.</span></div>
CY2022Q2 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
150000000 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
us-gaap Use Of Estimates
UseOfEstimates
The preparation of the financial statements in conformity with the accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet. Actual results could differ from those estimates.<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in the Company’s consolidated financial statements and accompanying notes as of the date of the consolidated financial statements. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts, and experience.</span></div>The Company’s accounting estimates and assumptions may change over time in response to COVID-19 and the change could be material in future periods. As of the date of issuance of these consolidated financial statements, the Company is not aware of any specific event or circumstances that would require the Company to update estimates, judgments or revise the carrying value of any assets or liabilities. Actual results may differ from those estimates or assumptions.
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10466000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9483000 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
918000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
421000 usd
CY2022Q2 qbts Receivable Research Incentives Current
ReceivableResearchIncentivesCurrent
2451000 usd
CY2021Q4 qbts Receivable Research Incentives Current
ReceivableResearchIncentivesCurrent
4774000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
2148000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
2114000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1529000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1116000 usd
CY2022Q2 us-gaap Deferred Costs Current
DeferredCostsCurrent
5671000 usd
CY2021Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
1250000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
23183000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
19158000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2772000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3249000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8118000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8578000 usd
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
262000 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
272000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1350000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1353000 usd
CY2022Q2 us-gaap Assets
Assets
35685000 usd
CY2021Q4 us-gaap Assets
Assets
32610000 usd
CY2022Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
2483000 usd
CY2021Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
2109000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8295000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3614000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1573000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1687000 usd
CY2022Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
21353000 usd
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
220000 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2595000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2665000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
36299000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10295000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6556000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6990000 usd
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
12903000 usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
12233000 usd
CY2022Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
20000 usd
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
54000 usd
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
18000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
55778000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
29590000 usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
137765828 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
137765828 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
137765828 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
137765828 shares
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
189881000 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
189881000 usd
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3341327 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3341327 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3166949 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3166949 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
2811000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2610000 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
147779000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
146240000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-350083000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-325268000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-10481000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-10443000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-20093000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3020000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
35685000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32610000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1371000 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1137000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3083000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2546000 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
586000 usd
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
448000 usd
us-gaap Cost Of Revenue
CostOfRevenue
1169000 usd
us-gaap Cost Of Revenue
CostOfRevenue
746000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
785000 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
689000 usd
us-gaap Gross Profit
GrossProfit
1914000 usd
us-gaap Gross Profit
GrossProfit
1800000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7072000 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6291000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13599000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12775000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3959000 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2508000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7606000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5030000 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1739000 usd
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1226000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3339000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2296000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
12770000 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
10025000 usd
us-gaap Operating Expenses
OperatingExpenses
24544000 usd
us-gaap Operating Expenses
OperatingExpenses
20101000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-11985000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-9336000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-22630000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-18301000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-350100000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
1746000 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
207000 usd
us-gaap Interest Expense
InterestExpense
2538000 usd
us-gaap Interest Expense
InterestExpense
385000 usd
CY2022Q2 us-gaap Government Assistance Amount
GovernmentAssistanceAmount
0 usd
CY2021Q2 us-gaap Government Assistance Amount
GovernmentAssistanceAmount
4586000 usd
us-gaap Government Assistance Amount
GovernmentAssistanceAmount
0 usd
us-gaap Government Assistance Amount
GovernmentAssistanceAmount
4586000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
533000 usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
289000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
353000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
604000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1213000 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4668000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2185000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4805000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-13198000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-4668000 usd
us-gaap Net Income Loss
NetIncomeLoss
-24815000 usd
us-gaap Net Income Loss
NetIncomeLoss
-13496000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
112023503 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
112023503 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
111877937 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
111877937 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
111981014 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
111981014 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
111865630 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
111865630 shares
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-13198000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-4668000 usd
us-gaap Net Income Loss
NetIncomeLoss
-24815000 usd
us-gaap Net Income Loss
NetIncomeLoss
-13496000 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
32000 usd
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-38000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-38000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
11000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13166000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4706000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24853000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13485000 usd
CY2022Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.99
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
32729000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
65000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
330000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
11000 usd
us-gaap Net Income Loss
NetIncomeLoss
-13496000 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
19639000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3020000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
140000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1600000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-38000 usd
us-gaap Net Income Loss
NetIncomeLoss
-24815000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-20093000 usd
us-gaap Net Income Loss
NetIncomeLoss
-24815000 usd
us-gaap Net Income Loss
NetIncomeLoss
-13496000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
705000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
747000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1600000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
330000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
459000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
497000 usd
us-gaap Inventory Write Down
InventoryWriteDown
265000 usd
us-gaap Inventory Write Down
InventoryWriteDown
219000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
1955000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
385000 usd
qbts Noncash Fee Expense
NoncashFeeExpense
583000 usd
qbts Noncash Fee Expense
NoncashFeeExpense
0 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
349000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-44000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
505000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
126000 usd
qbts Increase Decrease In Research Incentives Receivable
IncreaseDecreaseInResearchIncentivesReceivable
851000 usd
qbts Increase Decrease In Research Incentives Receivable
IncreaseDecreaseInResearchIncentivesReceivable
5339000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
301000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-39000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4449000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
288000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
107000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1764000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4578000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-733000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-54000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-324000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-427000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-459000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21499000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20268000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
175000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1069000 usd
us-gaap Payments For Software
PaymentsForSoftware
43000 usd
us-gaap Payments For Software
PaymentsForSoftware
196000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-218000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1265000 usd
qbts Proceeds From Government Program
ProceedsFromGovernmentProgram
3178000 usd
qbts Proceeds From Government Program
ProceedsFromGovernmentProgram
13458000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
19870000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
141000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
67000 usd
qbts Repayments Of Long Term Debt And Financing Obligation
RepaymentsOfLongTermDebtAndFinancingObligation
424000 usd
qbts Repayments Of Long Term Debt And Financing Obligation
RepaymentsOfLongTermDebtAndFinancingObligation
398000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22765000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13127000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-65000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
262000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
983000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8144000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9483000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21335000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10466000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13191000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
21000 usd
CY2022Q2 qbts Scientific Research And Experimental Development Investment Tax Credit
ScientificResearchAndExperimentalDevelopmentInvestmentTaxCredit
400000 usd
qbts Deferred Costs Incurrent But Not Yet Paid
DeferredCostsIncurrentButNotYetPaid
3734000 usd
qbts Deferred Costs Incurrent But Not Yet Paid
DeferredCostsIncurrentButNotYetPaid
0 usd
CY2022Q2 qbts Working Capital Deficit
WorkingCapitalDeficit
-13100000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-13200000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-4700000 usd
us-gaap Net Income Loss
NetIncomeLoss
-24800000 usd
us-gaap Net Income Loss
NetIncomeLoss
-13500000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21500000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20300000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10500000 usd
qbts Proceeds From Issuance Of Long Term Debt Gross
ProceedsFromIssuanceOfLongTermDebtGross
20000000 usd
CY2022Q2 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
150000000 usd
CY2022Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
5700000 usd
CY2021Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
1200000 usd
CY2022Q2 qbts Equity Securities Without Readily Determinable Fair Value Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueFairValueAmount
10200000 cad
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
562000 usd
CY2021Q2 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
271000 usd
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
366000 usd
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
567000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10500000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9500000 usd
qbts Proceeds From Issuance Of Long Term Debt Gross
ProceedsFromIssuanceOfLongTermDebtGross
20000000 usd
CY2021Q4 qbts Equity Securities Without Readily Determinable Fair Value Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueFairValueAmount
10200000 cad
CY2022Q2 qbts Equity Securities Without Readily Determinable Fair Value Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueFairValueAmount
1200000 usd
CY2021Q4 qbts Equity Securities Without Readily Determinable Fair Value Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueFairValueAmount
279000 usd
CY2022Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
1200000 usd
CY2021Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
5000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentration riskAgreements which potentially subject the Company to concentration risk consist principally of three customer agreements.
CY2021Q2 qbts Scientific Research And Experimental Development Investment Tax Credit
ScientificResearchAndExperimentalDevelopmentInvestmentTaxCredit
400000 usd
qbts Scientific Research And Experimental Development Investment Tax Credit
ScientificResearchAndExperimentalDevelopmentInvestmentTaxCredit
800000 usd
qbts Scientific Research And Experimental Development Investment Tax Credit
ScientificResearchAndExperimentalDevelopmentInvestmentTaxCredit
600000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1371000 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1137000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1371000 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1137000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3083000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2546000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3083000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2546000 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
918000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
535000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
421000 usd
CY2022Q2 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
41000 usd
CY2021Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
17000 usd
CY2022Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
959000 usd
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
438000 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2595000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2665000 usd
CY2022Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
20000 usd
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
54000 usd
CY2022Q2 qbts Contract With Customer Deposit Liability
ContractWithCustomerDepositLiability
21000 usd
CY2021Q4 qbts Contract With Customer Deposit Liability
ContractWithCustomerDepositLiability
21000 usd
CY2022Q2 qbts Contract With Customer Liability And Deposit
ContractWithCustomerLiabilityAndDeposit
2636000 usd
CY2021Q4 qbts Contract With Customer Liability And Deposit
ContractWithCustomerLiabilityAndDeposit
2740000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2719000 usd
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4713000 usd
qbts Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
2906000 usd
CY2021 qbts Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
4092000 usd
qbts Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
3010000 usd
CY2021 qbts Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
6086000 usd
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2615000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2719000 usd
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2600000 usd
CY2022Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2700000 usd
CY2021Q4 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.98
CY2021Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3614000 usd
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
6026000 usd
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1953000 usd
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1859000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1108000 usd
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
205000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
318000 usd
CY2022Q2 qbts Accrued Payroll Expenses Current
AccruedPayrollExpensesCurrent
149000 usd
CY2021Q4 qbts Accrued Payroll Expenses Current
AccruedPayrollExpensesCurrent
175000 usd
CY2022Q2 qbts Contract With Customer Deposit Liability Current
ContractWithCustomerDepositLiabilityCurrent
21000 usd
CY2021Q4 qbts Contract With Customer Deposit Liability Current
ContractWithCustomerDepositLiabilityCurrent
21000 usd
CY2022Q2 qbts Financing Liability Current
FinancingLiabilityCurrent
35000 usd
CY2021Q4 qbts Financing Liability Current
FinancingLiabilityCurrent
39000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8295000 usd
qbts Proceeds From Issuance Of Long Term Debt Gross
ProceedsFromIssuanceOfLongTermDebtGross
20000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
398000 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25225000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25050000 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22453000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21801000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2772000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3249000 usd
CY2022Q2 us-gaap Depreciation
Depreciation
309000 usd
CY2021Q2 us-gaap Depreciation
Depreciation
344000 usd
us-gaap Depreciation
Depreciation
705000 usd
us-gaap Depreciation
Depreciation
747000 usd
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
29844000 usd
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
13624000 usd
CY2021 qbts Proceeds From Issuance Of Long Term Debt Gross
ProceedsFromIssuanceOfLongTermDebtGross
16786000 usd
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
399000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
606000 usd
CY2021 us-gaap Interest Expense Debt
InterestExpenseDebt
0 usd
qbts Final Payment Fee Debt
FinalPaymentFeeDebt
583000 usd
CY2021 qbts Final Payment Fee Debt
FinalPaymentFeeDebt
0 usd
qbts Debt Instrument Foreign Exchange Gain Loss
DebtInstrumentForeignExchangeGainLoss
452000 usd
CY2021 qbts Debt Instrument Foreign Exchange Gain Loss
DebtInstrumentForeignExchangeGainLoss
167000 usd
CY2022Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
50183000 usd
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
29844000 usd
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
17391000 usd
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
11948000 usd
CY2021 qbts Debt Instrument Discount
DebtInstrumentDiscount
7167000 usd
qbts Debt Instrument Discount
DebtInstrumentDiscount
130000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1349000 usd
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1728000 usd
qbts Debt Instrument Discount Foreign Exchange Gain Loss
DebtInstrumentDiscountForeignExchangeGainLoss
-245000 usd
CY2021 qbts Debt Instrument Discount Foreign Exchange Gain Loss
DebtInstrumentDiscountForeignExchangeGainLoss
4000 usd
CY2022Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
15927000 usd
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
17391000 usd
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
34256000 usd
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
12453000 usd
CY2022Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
21353000 usd
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
220000 usd
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
12903000 usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
12233000 usd
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
34256000 usd
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
12453000 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.81
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y11M15D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
16336134 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.81
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y6M18D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
80179000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
174378 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.81
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
840002 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.81
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
11077 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.81
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
15310677 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
75144000 usd
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
4698271 shares
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.81
qbts Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageRemainingContractualTerm
P7Y9M7D
CY2022Q2 qbts Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIntrinsicValue
73479000 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
10612406 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.81
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y5M4D
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
52098000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.62
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1703000 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
112023503 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
111877937 shares
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
816000 usd
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
169000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1600000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
330000 usd
CY2021Q4 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P10Y6M
CY2021Q4 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6800000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-13198000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-4668000 usd
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
112023503 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
111877937 shares
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Net Income Loss
NetIncomeLoss
-24815000 usd
us-gaap Net Income Loss
NetIncomeLoss
-13496000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
111981014 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
111981014 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
111865630 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
111865630 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1371000 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1137000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3083000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2546000 usd
CY2022Q2 us-gaap Noncurrent Assets
NoncurrentAssets
10890000 usd
CY2021Q4 us-gaap Noncurrent Assets
NoncurrentAssets
11827000 usd
us-gaap Net Income Loss
NetIncomeLoss
-24800000 usd
us-gaap Net Income Loss
NetIncomeLoss
-13500000 usd

Files In Submission

Name View Source Status
0001907982-22-000006-index-headers.html Edgar Link pending
0001907982-22-000006-index.html Edgar Link pending
0001907982-22-000006.txt Edgar Link pending
0001907982-22-000006-xbrl.zip Edgar Link pending
exhibit311.htm Edgar Link pending
exhibit312.htm Edgar Link pending
exhibit321.htm Edgar Link pending
exhibit322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
qbts-20220630.htm Edgar Link pending
qbts-20220630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
qbts-20220630_pre.xml Edgar Link unprocessable
qbts-20220630_lab.xml Edgar Link unprocessable
qbts-20220630_cal.xml Edgar Link unprocessable
qbts-20220630_def.xml Edgar Link unprocessable
qbts-20220630_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable